Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Quality Improvement Solutions for the Diagnosis and Management of Migraine and Headache DisordersQuality Improvement Internal Medicine Canada, USA Shared Decision Making in Hemophilia Patient CareRelease Date:Quality Improvement Rare Disease China Real-World Atopic Dermatitis: Italian Insights GrantRelease Date:Research Inflammation & Immunology Italy Optimizing Care for patients with Muscle Invasive Bladder Cancer (MIBC)Release Date:Quality Improvement Oncology Canada Optimizing HRRm Testing and Workflow Integration in mCSPCRelease Date:Quality Improvement, Research Oncology Canada Driving Timely Biomarker Testing to Optimize Treatment Decisions for Colorectal Cancer Patients Across CanadaRelease Date:Partner: Colorectal Cancer Canada (CCC)Quality Improvement, Research Oncology Canada Optimizing Disease Management to Improve Alopecia Areata Quality of CareRelease Date:Quality Improvement Inflammation & Immunology China Optimizing Antimicrobial Stewardship (AMS) Interventions and Outcomes in Clinical Outcomes, Optimal Use and Resource UtilizatioRelease Date:Research Inflammation & Immunology China Antimicrobial Stewardship —Treatment optimization under antibiotics appropriate use policy in ChinaRelease Date:Research Inflammation & Immunology China Research on Exploring Disease Assessment and Prioritizing Systematic Treatment for VitiligoRelease Date:Research Inflammation & Immunology China Title Grant Type Focus Area Country Application Due Date Invasive Fungal Infections (Emerging market countries listed in Geographic Scope)Release Date:Education Hospital All Accelerate Promotion and Dissemination of Appropriate Atopic Dermatitis Diagnosis, Treatment, and Management GuidanceRelease Date:Partner: Japanese Dermatological AssociationQuality Improvement Inflammation & Immunology Japan Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research in Latin AmericaRelease Date:Research Rare Disease All Pediatric Endocrinology FellowshipRelease Date:Fellowship Rare Disease USA Growth Hormone Research- United StatesRelease Date:Research Rare Disease USA Treatment of acute SARS-CoV-2 infection and management of post-COVID conditions in outpatient settings (European countries)Release Date:Education Hospital All Topical Hemostasis in Hospital Outpatient and Ambulatory SurgeryRelease Date:Education Hospital USA Education for Improving Appropriate Diagnosis and Treatment for Venous ThromboembolismRelease Date:Education Internal Medicine Japan Establishment of System for Early Detection of Atrial Fibrillation and Prevention of Cardiogenic EmbolismRelease Date:Quality Improvement Internal Medicine Japan Atopic Dermatitis and Alopecia AreataRelease Date:Quality Improvement Inflammation & Immunology Canada Advances in Atopic Dermatitis & Alopecia Areata for Community Pharmacists & Managed Care Health Care ProfessionalsRelease Date:Education Inflammation & Immunology USA Bladder Cancer Canada-EMD Serono-Pfizer Quality Improvement Request for ProposalsRelease Date:Partner: Bladder Cancer Canada, EMD SeronoQuality Improvement Oncology Canada